The 'Theranos 2.0' Gamble: Billy Evans and Haemanthus

Billy Evans, husband of disgraced Theranos founder Elizabeth Holmes, is positioning himself at the center of a new diagnostic venture called Haemanthus, as Wired first reported. While Evans has attempted to reassure social media followers that the company is not "Theranos 2.0," Wired reports that the startup's stated goal—bringing blood, urine, and saliva testing into American homes via a countertop machine—closely mirrors the original mission of Theranos.

According to Wired, Haemanthus was founded by Evans in 2022. While a person familiar with the business told The Wall Street Journal that Holmes is not involved, Wired notes that the couple are both shown on fundraising calls in the documentary *You Can See Everything*. In the film, Evans agrees with the characterization that he and Holmes are creating "Theranos 2.0," and the pair discuss collaborating on product ideas from prison.

Despite the association, Wired reports that Holmes' name does not appear in any Haemanthus incorporation documents. The company has released no products and maintains a minimal digital presence. However, the venture has secured a patent granted January 21, 2025, for a Raman Spectroscopy System. Unlike the miniaturized diagnostic techniques attempted by Theranos, Haemanthus' technology utilizes lasers to fire high-power light sources into biological samples to read information.

Evans, an MIT graduate and heir to a prominent San Diego hotelier family, previously worked at LinkedIn and Luminar Technologies. He has not responded to specific questions regarding the venture, though he told *All-In* podcast cohost David Friedberg that he might eventually view the project as the "dumbest thing" he has ever done.